Hera Med Ltd
ASX:HMD
Income Statement
Earnings Waterfall
Hera Med Ltd
Income Statement
Hera Med Ltd
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
+79%
|
0
+5%
|
0
-36%
|
0
-58%
|
0
-38%
|
0
+425%
|
0
+59%
|
0
+63%
|
0
+13%
|
1
+61%
|
0
-19%
|
0
-26%
|
0
-11%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
(0)
N/A
|
(0)
+52%
|
0
N/A
|
0
-62%
|
0
-39%
|
0
+108%
|
0
+304%
|
0
+69%
|
0
+91%
|
0
+38%
|
0
+23%
|
0
-40%
|
0
-1%
|
0
-13%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(6)
|
(4)
|
(5)
|
(5)
|
(7)
|
(7)
|
(6)
|
(4)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
(3)
|
|
| Research & Development |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(4)
-28%
|
(3)
+12%
|
(3)
+5%
|
(3)
-12%
|
(4)
-13%
|
(6)
-55%
|
(4)
+32%
|
(5)
-21%
|
(5)
+3%
|
(7)
-41%
|
(7)
+2%
|
(5)
+17%
|
(4)
+28%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
0
|
(0)
|
0
|
0
|
(2)
|
(3)
|
(3)
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Total Other Income |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(5)
-20%
|
(3)
+31%
|
(3)
+1%
|
(3)
-8%
|
(4)
-12%
|
(9)
-127%
|
(7)
+16%
|
(7)
-4%
|
(5)
+33%
|
(7)
-37%
|
(7)
+0%
|
(5)
+19%
|
(5)
+17%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
(9)
|
(7)
|
(7)
|
(5)
|
(7)
|
(7)
|
(5)
|
(5)
|
|
| Net Income (Common) |
(4)
N/A
|
(5)
-20%
|
(3)
+31%
|
(3)
+1%
|
(3)
-8%
|
(4)
-12%
|
(9)
-127%
|
(7)
+16%
|
(7)
-4%
|
(5)
+33%
|
(7)
-37%
|
(7)
+0%
|
(5)
+19%
|
(5)
+17%
|
|
| EPS (Diluted) |
-0.1
N/A
|
-0.05
+50%
|
-0.04
+20%
|
-0.03
+25%
|
-0.03
N/A
|
-0.02
+33%
|
-0.05
-150%
|
-0.04
+20%
|
-0.03
+25%
|
-0.02
+33%
|
-0.03
-50%
|
-0.02
+33%
|
-0.01
+50%
|
-0.01
N/A
|
|